Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile
- Development stage
- Unknown
- Lead developer
- C4 Therapeutics, Inc.
- Modality
- Small Molecules
01
Overview
A small molecule experimental compound belonging to the class of benzonitriles. It is not approved for any clinical use and has no known marketed brand names. The compound features a complex fused heterocyclic structure with multiple stereocenters and a trifluoromethyl group. It is primarily referenced in structural biology databases as an inhibitor used in crystallographic studies of protein-ligand interactions[5][8]. No detailed mechanism of action or primary indication is available in public sources.
- Other names
- 2-chloro-4-{(Z)-[(1R,7S,7aS)-7-hydroxy-1-(trifluormethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-yliden]amino}-3-methylbenzonitrilBenzontrile, 2-chloro-3-methyl-4-[ [(1R,3Z,7S,7aS)-tetrahydro-7-hydroxy-1-(trifluoromethyl)-1H-pyrrolo[1,c]oxazolylidene]amino ]-LGB (PDB ligand code)DB08088 (DrugBank accession number)
Beyond the preview
Go deeper on 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile.